A fluorescence-based method to assess plasma protein extravasation in rat dura mater using confocal laser scanning microscopy

Brain Research Protocols

Volumn 12, Issue 2, 2003, Pages 77-82

  Schuh Hofer, Sigrid ^a   Boehnke, Carsten ^a   Reuter, Uwe ^a   Siekmann, Wiebke ^a   Lindauer, Ute ^a   Arnold, Guy ^a   Dirnagl, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Confocal laser scanning microscopy; Dura mater; Evans Blue; Migraine; Neurogenic inflammation

Indexed keywords

EVANS BLUE; FLUORESCENT DYE; PLASMA PROTEIN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN SUCCINATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CALCULATION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DURA MATER; ELECTROSTIMULATION; FLUORESCENCE; MALE; MIGRAINE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; STATISTICAL SIGNIFICANCE; TRIGEMINUS GANGLION;

EID: 0242569636     PISSN: 1385299X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresprot.2003.08.003     Document Type: Article

References (14)

1. Buzzi M.G., Moskowitz M.A. The antimigraine drug, sumatriptan (GR 43175), selectively blocks neurogenic plasma protein extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99:1990;202-206.
2. Buzzi M.G., Sakas D.E., Moskowitz M.A. Indomethacin and acetylsalicyclic acid block neurogenic plasma protein extravasation in rat dura mater. Eur. J. Pharmacol. 165:1989;251-258.
3. Buzzi M.G., Bonamini M., Moskowitz M.A. Neurogenic model of migraine. Cephalalgia. 15:1995;277-280.
4. Dimitriadou V., Buzzi M.G., Theoharides T.C., Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 48:1992;187-203.
5. Johnson K.W., Phebus L.A. A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation. J. Neurosci. Methods. 81:1998;19-24.
6. Limmroth V., Cutrer F.M., Moskowitz M.A. Neurotransmitters and neuropeptides in headache. Curr. Opin. Neurol. 9:1996;206-210.
7. Limmroth V., Katsarava Z., Liedert B., Guehring H., Schmitz K., Diener H.C., Michel M.C. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain. 92:2001;101-106.
8. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7:1987;4129-4136.
9. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 43(6 Supplement 3):1993;S16-S20.
10. Saria A., Lundberg J.M. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods. 8:1983;41-49.
11. Shepeard S.L., Williamson D.J., Williams J., Hill R.G., Hargreaves R.J. Comparison of the effects of Sumatriptan and the NK1 Antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;255-261.
12. 1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology. 36:1997;525-533.
13. Williamson D.J., Hargreaves R.J. Neurogenic inflammation in the context of migraine. Microsc. Res. Tech. 53:2001;167-178.
14. Yu X.J., Cutrer F.M., Moskowitz M.A., Waeber C. The 5-HT1D receptor agonist GR-127, 935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater. Neuropharmacology. 36:1997;83-91.